Featured Products

My Quote Request

No products added yet

6505-01-427-1066

20 Products

ZYRTEC

CETIRIZINE TABLETS

NSN, MFG P/N

6505014271066

NSN

6505-01-427-1066

View More Info

ZYRTEC

CETIRIZINE TABLETS

NSN, MFG P/N

6505014271066

NSN

6505-01-427-1066

MFG

PFIZER INC. DBA PFIZER

Description

GENERAL CHARACTERISTICS ITEM DESCRIPTION: 5 MG; 100'S; THPE TO ZYRTEC BY PFIZER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CETRIZINE TABLETS 5MG 100S

NDC00069-5500-66

CETIRIZINE TABLETS

NSN, MFG P/N

6505014271066

NSN

6505-01-427-1066

View More Info

NDC00069-5500-66

CETIRIZINE TABLETS

NSN, MFG P/N

6505014271066

NSN

6505-01-427-1066

MFG

PFIZER INC. DBA PFIZER

Description

GENERAL CHARACTERISTICS ITEM DESCRIPTION: 5 MG; 100'S; THPE TO ZYRTEC BY PFIZER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CETRIZINE TABLETS 5MG 100S

96-0105

LISINOPRIL TABLETS,USP

NSN, MFG P/N

6505014282320

NSN

6505-01-428-2320

View More Info

96-0105

LISINOPRIL TABLETS,USP

NSN, MFG P/N

6505014282320

NSN

6505-01-428-2320

MFG

DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.500 MILLIGRAMS LISINOPRIL ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LISINOPRIL TABLETS USP 2.5ML 100S
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE

NDC00006-0015-58

LISINOPRIL TABLETS,USP

NSN, MFG P/N

6505014282320

NSN

6505-01-428-2320

View More Info

NDC00006-0015-58

LISINOPRIL TABLETS,USP

NSN, MFG P/N

6505014282320

NSN

6505-01-428-2320

MFG

MERCK SHARP & DOHME CORP. DBA MERCK DIV US HUMAN HEALTH

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.500 MILLIGRAMS LISINOPRIL ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LISINOPRIL TABLETS USP 2.5ML 100S
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE

NDC00310-0135-11

LISINOPRIL TABLETS,USP

NSN, MFG P/N

6505014282320

NSN

6505-01-428-2320

View More Info

NDC00310-0135-11

LISINOPRIL TABLETS,USP

NSN, MFG P/N

6505014282320

NSN

6505-01-428-2320

MFG

ASTRAZENECA LP

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.500 MILLIGRAMS LISINOPRIL ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LISINOPRIL TABLETS USP 2.5ML 100S
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE

ZESTRIL

LISINOPRIL TABLETS,USP

NSN, MFG P/N

6505014282320

NSN

6505-01-428-2320

View More Info

ZESTRIL

LISINOPRIL TABLETS,USP

NSN, MFG P/N

6505014282320

NSN

6505-01-428-2320

MFG

ASTRAZENECA LP

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.500 MILLIGRAMS LISINOPRIL ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LISINOPRIL TABLETS USP 2.5ML 100S
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE

0300-04

SKIN PROTECTIVE OINTMENT,MOISTURE BARRIER

NSN, MFG P/N

6505014286629

NSN

6505-01-428-6629

View More Info

0300-04

SKIN PROTECTIVE OINTMENT,MOISTURE BARRIER

NSN, MFG P/N

6505014286629

NSN

6505-01-428-6629

MFG

COLONIAL HOSPITAL SUPPLY CO

Description

MEDICAMENT BASE TYPE: POLYETHYLENE GLYCOL
PRIMARY CONTAINER CONTENT QUANTITY: 4.000 OUNCES
PRIMARY CONTAINER TYPE: TUBE, PLASTIC SQUEEZE
SPECIAL FEATURES: PROSHIELD PLUS SKIN PROTECTANT; GREASELESS; FRAGRANCE FREE; MOISTURE BARRIER,
TOTAL PRIMARY CONTAINER QUANTITY: 12
USAGE DESIGN: TO PROTECT AGAINST INCONTINENCE

D8063-52

GENTAMICIN SULFATE IN SODIUM CHLORIDE INJECTION

NSN, MFG P/N

6505014295988

NSN

6505-01-429-5988

View More Info

D8063-52

GENTAMICIN SULFATE IN SODIUM CHLORIDE INJECTION

NSN, MFG P/N

6505014295988

NSN

6505-01-429-5988

MFG

KENDALL MCGAW

Description

PRIMARY CONTAINER CONTENT QUANTITY: 100.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG WITH HANGING DEVICE, PLASTIC
SECONDARY CONTAINER TYPE: PACKAGE
SPECIAL FEATURES: 60 MG GENTAMICIN IN 0.9% SODIUM CHLORIDE.
TOTAL PRIMARY CONTAINER QUANTITY: 24

NDC00264-5806-32

GENTAMICIN SULFATE IN SODIUM CHLORIDE INJECTION

NSN, MFG P/N

6505014295988

NSN

6505-01-429-5988

View More Info

NDC00264-5806-32

GENTAMICIN SULFATE IN SODIUM CHLORIDE INJECTION

NSN, MFG P/N

6505014295988

NSN

6505-01-429-5988

MFG

KENDALL MCGAW

Description

PRIMARY CONTAINER CONTENT QUANTITY: 100.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG WITH HANGING DEVICE, PLASTIC
SECONDARY CONTAINER TYPE: PACKAGE
SPECIAL FEATURES: 60 MG GENTAMICIN IN 0.9% SODIUM CHLORIDE.
TOTAL PRIMARY CONTAINER QUANTITY: 24

96-0327

SULFISOXAZOLE TABLETS,USP

NSN, MFG P/N

6505014296618

NSN

6505-01-429-6618

View More Info

96-0327

SULFISOXAZOLE TABLETS,USP

NSN, MFG P/N

6505014296618

NSN

6505-01-429-6618

MFG

DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.500 GRAMS SULFISOXAZOLE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SULFISOXAZOLE TAGBLETS USP 0.5GM 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: REPLACEMENT FOR NSN 6505-00-146-4425

NDC00172-2218-60

SULFISOXAZOLE TABLETS,USP

NSN, MFG P/N

6505014296618

NSN

6505-01-429-6618

View More Info

NDC00172-2218-60

SULFISOXAZOLE TABLETS,USP

NSN, MFG P/N

6505014296618

NSN

6505-01-429-6618

MFG

ZENITH LABORATORIES INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.500 GRAMS SULFISOXAZOLE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SULFISOXAZOLE TAGBLETS USP 0.5GM 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: REPLACEMENT FOR NSN 6505-00-146-4425

NDC00781-1015-81

SULFISOXAZOLE TABLETS,USP

NSN, MFG P/N

6505014296618

NSN

6505-01-429-6618

View More Info

NDC00781-1015-81

SULFISOXAZOLE TABLETS,USP

NSN, MFG P/N

6505014296618

NSN

6505-01-429-6618

MFG

GENEVA PHARMACEUTICALS INC

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.500 GRAMS SULFISOXAZOLE ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SULFISOXAZOLE TAGBLETS USP 0.5GM 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: REPLACEMENT FOR NSN 6505-00-146-4425

96-0309

SODIUM AND POTASSIUM PHOSPHATES,MONOBASIC AND DIBASIC,POWDER

NSN, MFG P/N

6505014296621

NSN

6505-01-429-6621

View More Info

96-0309

SODIUM AND POTASSIUM PHOSPHATES,MONOBASIC AND DIBASIC,POWDER

NSN, MFG P/N

6505014296621

NSN

6505-01-429-6621

MFG

DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA

Description

III PART NAME ASSIGNED BY CONTROLLING AGENCY: SODIUM AND POTASSIUM PHOSPHATES MONOBASIC AND DIBASIC POWDER 100S
SPECIAL FEATURES: 1.250 GRAMS, 100 UNIT DOSE PACKETS

NDC17314-9313-02

SODIUM AND POTASSIUM PHOSPHATES,MONOBASIC AND DIBASIC,POWDER

NSN, MFG P/N

6505014296621

NSN

6505-01-429-6621

View More Info

NDC17314-9313-02

SODIUM AND POTASSIUM PHOSPHATES,MONOBASIC AND DIBASIC,POWDER

NSN, MFG P/N

6505014296621

NSN

6505-01-429-6621

MFG

ALZA CORP ALZA PHARMACEUTICALS DIV

Description

III PART NAME ASSIGNED BY CONTROLLING AGENCY: SODIUM AND POTASSIUM PHOSPHATES MONOBASIC AND DIBASIC POWDER 100S
SPECIAL FEATURES: 1.250 GRAMS, 100 UNIT DOSE PACKETS

2A6333

AMINO ACIDS INJECTION WITH ELECTROLYTES

NSN, MFG P/N

6505014297948

NSN

6505-01-429-7948

View More Info

2A6333

AMINO ACIDS INJECTION WITH ELECTROLYTES

NSN, MFG P/N

6505014297948

NSN

6505-01-429-7948

MFG

BAXTER HEALTHCARE CORPORATION

Description

PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, GLASS
SECONDARY CONTAINER TYPE: PACKAGE
SPECIAL FEATURES: NOVAMINE 15%; ACETATE 151 ELECTROLYTES; 5.2 - 6.0 PH; 1388 MOSMOL /L;
TOTAL PRIMARY CONTAINER QUANTITY: 10

NDC00338-0494-03

AMINO ACIDS INJECTION WITH ELECTROLYTES

NSN, MFG P/N

6505014297948

NSN

6505-01-429-7948

View More Info

NDC00338-0494-03

AMINO ACIDS INJECTION WITH ELECTROLYTES

NSN, MFG P/N

6505014297948

NSN

6505-01-429-7948

MFG

BAXTER HEALTHCARE CORPORATION

Description

PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, GLASS
SECONDARY CONTAINER TYPE: PACKAGE
SPECIAL FEATURES: NOVAMINE 15%; ACETATE 151 ELECTROLYTES; 5.2 - 6.0 PH; 1388 MOSMOL /L;
TOTAL PRIMARY CONTAINER QUANTITY: 10

5B5195

PERITONEAL DIALYSIS SOLUTION

NSN, MFG P/N

6505014298574

NSN

6505-01-429-8574

View More Info

5B5195

PERITONEAL DIALYSIS SOLUTION

NSN, MFG P/N

6505014298574

NSN

6505-01-429-8574

MFG

BAXTER HEALTHCARE CORPORATION

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 4.250 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT AND 132.000 MILLIEQUIVALENTS SODIUM CHLORIDE PER LITER AND 3.500 MILLIEQUIVALENTS CALCIUM CHLORIDE PER LITER AND 0.500 MILLIEQUIVALENTS MAGNESIUM CHLORIDE PER LITER AND 96.000 MILLIEQUIVALENTS CHLORIDE ION
ADMINISTRATION: INTRAVENOUS
PRIMARY CONTAINER CONTENT QUANTITY: 5000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG WITH HANGING DEVICE, PLASTIC
SPECIAL FEATURES: WITH 2 PORTS (MEDICAL AND OUTLET PORT); COMPOSITION PER 100 ML; DEXTROSE 1.5 GRAMS; SODIUM CHLORIDE 538 MG; SODIUM LACTATE 448 MG; CALCIUM CHLORIDE 25.7 MG; MAGESIUM CHLORIDE 5.08 MG.
TOTAL PRIMARY CONTAINER QUANTITY: 2
~1: PER LITER AND 40.000 MILLIEQUIVALENTS SODIUM LACTATE PER LITER

2B7126

SODIUM CHLORIDE IRRIGATION,USP

NSN, MFG P/N

6505014298580

NSN

6505-01-429-8580

View More Info

2B7126

SODIUM CHLORIDE IRRIGATION,USP

NSN, MFG P/N

6505014298580

NSN

6505-01-429-8580

MFG

BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.900 PERCENTAGE, W/V SODIUM CHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: TOPICAL
FLAVOR: ANY ACCEPTABLE
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 2000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
SPECIAL FEATURES: BAG WITH TWO ATTACHED OUTLET PORTS; WITH HANGER STRAP; PLASTIC BAG SUPPLIED WITH OVERPOUCH.
TOTAL PRIMARY CONTAINER QUANTITY: 6

NDC00338-0047-46

SODIUM CHLORIDE IRRIGATION,USP

NSN, MFG P/N

6505014298580

NSN

6505-01-429-8580

View More Info

NDC00338-0047-46

SODIUM CHLORIDE IRRIGATION,USP

NSN, MFG P/N

6505014298580

NSN

6505-01-429-8580

MFG

BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.900 PERCENTAGE, W/V SODIUM CHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: TOPICAL
FLAVOR: ANY ACCEPTABLE
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 2000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
SPECIAL FEATURES: BAG WITH TWO ATTACHED OUTLET PORTS; WITH HANGER STRAP; PLASTIC BAG SUPPLIED WITH OVERPOUCH.
TOTAL PRIMARY CONTAINER QUANTITY: 6

2B0882

THEOPHYLLINE IN DEXTROSE INJECTION,USP

NSN, MFG P/N

6505014298583

NSN

6505-01-429-8583

View More Info

2B0882

THEOPHYLLINE IN DEXTROSE INJECTION,USP

NSN, MFG P/N

6505014298583

NSN

6505-01-429-8583

MFG

BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 400.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT AND 5.000 PERCENTAGE, V/V DEXTROSE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 250.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
SPECIAL FEATURES: 24 UNITS PER PACKAGE.